help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, G.
Right arrow Articles by Cooke, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, G.
Right arrow Articles by Cooke, N. E.

Journal of Clinical Endocrinology & Metabolism, Vol 73, 1175-1179, Copyright © 1991 by Endocrine Society


ARTICLES

Binding of human growth hormone (GH)-variant (placental GH) to GH- binding proteins in human plasma

G Baumann, N Davila, MA Shaw, J Ray, SA Liebhaber and NE Cooke
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

Human GH-variant (hGH-V) is a natural GH analog arising from the hGH-V gene. It is expressed in the placenta and secreted into the maternal circulation during the second half of pregnancy. To gain information about its bioactivity in man, we examined the interaction of hGH-V with the high affinity GH-binding protein/receptor (GH-BP) in human plasma. hGH-V was equipotent with pituitary hGH (hGH-N) as a ligand for the GH- BP. hGH-N/hGH-V chimeric proteins, where the sequences encoded by exon 3 (amino acid residues 32-71, thought to be exposed on the molecule's surface and involved in receptor binding) were exchanged, also bound with similarly high affinities. A corresponding hGH-N/rat PRL chimeric protein had 25-fold reduced affinity for the GH-BP. We conclude that hGH-V is a potent somatogen in man, and that some of the manifestations of late pregnancy, such as increased insulin-like growth factor-I levels and coarsening of features, are probably related to the high circulating levels of hGH-V. GH-BP measurements in pregnancy must take into account BP saturation by endogenous hGH-V.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. Zhang, X. Wu, H. Wang, A. M. Mikheev, Q. Mao, and J. D. Unadkat
Effect of Pregnancy on Cytochrome P450 3a and P-Glycoprotein Expression and Activity in the Mouse: Mechanisms, Tissue Specificity, and Time Course
Mol. Pharmacol., September 1, 2008; 74(3): 714 - 723.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Fuglsang, P. Sandager, N. Moller, S. Fisker, H. Orskov, and P. Ovesen
Kinetics and secretion of placental growth hormone around parturition.
Eur. J. Endocrinol., March 1, 2006; 154(3): 449 - 457.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-C. Lacroix, J. Guibourdenche, T. Fournier, I. Laurendeau, A. Igout, V. Goffin, J. Pantel, V. Tsatsaris, and D. Evain-Brion
Stimulation of Human Trophoblast Invasion by Placental Growth Hormone
Endocrinology, May 1, 2005; 146(5): 2434 - 2444.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Chellakooty, L. Skibsted, S. O. Skouby, A.-M. Andersson, J. H. Petersen, K. M. Main, N. E. Skakkebaek, and A. Juul
Longitudinal Study of Serum Placental GH in 455 Normal Pregnancies: Correlation to Gestational Age, Fetal Gender, and Weight
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2734 - 2739.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society